X0306 4 2020-03-20 0 0000722830 IMMUNOMEDICS INC IMMU 0001701815 Aghazadeh Behzad C/O AVORO CAPITAL ADVISORS LLC 110 GREENE STREET, SUITE 800 NEW YORK NY 10012 1 0 1 1 see remarks 0001633313 Avoro Capital Advisors LLC C/O AVORO CAPITAL ADVISORS LLC 110 GREENE STREET, SUITE 800 NEW YORK NY 10012 1 0 1 1 see remarks Common Stock, $0.01 par value per share 2020-03-20 4 A 0 100000 0 A 100000 D Common Stock, $0.01 par value per share 13516 D Common Stock, $0.01 par value per share 24500000 I See footnote Dr. Aghazadeh was granted restricted stock units pursuant to the Issuer's 2014 Long-Term Incentive Plan. 1/3 of the restricted stock units vest on each of the first, second, and third anniversary of the date of grant, subject to Dr. Aghazadeh's continued service as the Company's Executive Chairman. Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock.. Dr. Aghazadeh serves as the portfolio manager and controlling person of Avoro Capital Advisors LLC (formerly venBio Select Advisor LLC), a Delaware limited liability company (the "Investment Manager"). The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein. The securities reported herein are held on behalf of accounts managed by the Investment Manager. The Investment Manager may be deemed a director by deputization of Immunomedics, Inc. (the "Issuer") by virtue of the fact that Dr. Aghazadeh currently serves on the board of directors of the Issuer. /s/ Behzad Aghazadeh 2020-03-20 Avoro Capital Advisors LLC, by: /s/ Behzad Aghazadeh, authorized signatory 2020-03-20